Ping An Ventures logo

Ping An Ventures

Asia, Shandong, China, Pudong

Description

Ping An Ventures is a professional VC under Ping An Insurance (Group) Company of China, Ltd. with focused interest in start-ups of emerging.

Investor Profile

Ping An Ventures has made 20 investments, with 0 in the past 12 months and 10% as lead.

Stage Focus

  • Series A (40%)
  • Series B (25%)
  • Series Unknown (10%)
  • Series D (10%)
  • Private Equity (10%)
  • Series C (5%)

Country Focus

  • United States (55%)
  • China (40%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Pharmaceutical
  • Health Diagnostics
  • E-commerce
  • Therapeutics
  • Genetics
  • Oncology
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ping An Ventures frequently co-invest with?

HC
Asia, Shanghai, China, Shanghai
Co-Investments: 2
AstraZeneca
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 2
Shunwei Capital
Asia, Beijing, China, Beijing
Co-Investments: 2
ZhenFund
Asia, Beijing, China, Beijing
Co-Investments: 2
Bay City Capital
North America, California, United States, San Francisco
Co-Investments: 2
SIG China (SIG Asia Investments)
Asia, Shanghai, China, Huangpu
Co-Investments: 2
GF Xinde Investment Management
Asia, Guangdong, China, Guangzhou
Co-Investments: 2
GGV Capital
North America, California, United States, Menlo Park
Co-Investments: 2
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 3
Trustbridge Partners
North America, Massachusetts, United States, Boston
Co-Investments: 3

Which angels does Ping An Ventures often collaborate with?

Patrick Cheung
Asia, Hong Kong
Shared Deals: 1
LL
North America, California, United States
Shared Deals: 1

What are some of recent deals done by Ping An Ventures?

Xiaoqule

Hangzhou, Zhejiang, China

Xiaoqule is a Chinese community-focused e-commerce platform.

E-CommerceRetailSocial Entrepreneurship
Series ANov 20, 2018
Amount Raised: $108,000,000
Global Scanner

Hangzhou, Zhejiang, China

Global Scanner is a social e-commerce platform targeting the middle-class in China.

E-Commerce
Series ANov 19, 2018
Amount Raised: $108,000,000
NextCure

Beltsville, Maryland, United States

NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.

BiopharmaBiotechnologyHealth CareOncology
Series BNov 13, 2018
Amount Raised: $93,000,000
Tmunity Therapeutics

Philadelphia, Pennsylvania, United States

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells.

BiotechnologyGeneticsHealth CareManufacturingTherapeutics
Series AApr 19, 2018
Amount Raised: $35,000,000
Hua Medicine

Shanghai, Shanghai, China

Hua Medicine is a clinical-stage, innovative drug development company in China.

BiotechnologyHealth CareLife ScienceMedicalPharmaceutical
Series DMar 27, 2018
Amount Raised: $117,400,000
Rani Therapeutics

San Jose, California, United States

Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.

BiotechnologyPharmaceuticalTherapeutics
Series UnknownFeb 7, 2018
Amount Raised: $53,000,000
Tmunity Therapeutics

Philadelphia, Pennsylvania, United States

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells.

BiotechnologyGeneticsHealth CareManufacturingTherapeutics
Series AJan 23, 2018
Amount Raised: $100,000,000
KBP Biosciences

Princeton, New Jersey, United States

A multinational clinical stage biotechnology company.

BiotechnologyHealth CarePharmaceutical
Series AJan 5, 2018
Amount Raised: $76,000,000
Rogrand

Beijing, Beijing, China

Rogrand is a Chinese pharmaceutical industry chain service platform.

E-CommercePharmaceutical
Series CDec 21, 2017
Fabric Genomics (formerly Omicia)

Oakland, California, United States

Global healthcare platform for genomics-driven precision medicine. Fabric' proven AI algorithms power genomic insights.

Artificial Intelligence (AI)BioinformaticsBiotechnologyGeneticsHealth CarePrecision Medicine
Series BJun 8, 2016
Amount Raised: $23,000,000